S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.17 (+0.35%)
AAPL   176.76 (+1.13%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.60 (+0.27%)
AMZN   131.38 (+1.75%)
TSLA   246.75 (+0.76%)
NVDA   424.01 (+1.90%)
NIO   8.39 (-1.64%)
BABA   87.11 (-1.35%)
AMD   96.86 (+0.69%)
T   15.07 (-0.33%)
F   12.67 (+1.93%)
MU   68.73 (-0.22%)
CGC   0.98 (+17.14%)
GE   111.72 (+0.42%)
DIS   80.83 (-0.52%)
AMC   8.31 (+9.06%)
PFE   32.70 (+0.03%)
PYPL   58.45 (+0.98%)
NFLX   384.59 (+1.26%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.17 (+0.35%)
AAPL   176.76 (+1.13%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.60 (+0.27%)
AMZN   131.38 (+1.75%)
TSLA   246.75 (+0.76%)
NVDA   424.01 (+1.90%)
NIO   8.39 (-1.64%)
BABA   87.11 (-1.35%)
AMD   96.86 (+0.69%)
T   15.07 (-0.33%)
F   12.67 (+1.93%)
MU   68.73 (-0.22%)
CGC   0.98 (+17.14%)
GE   111.72 (+0.42%)
DIS   80.83 (-0.52%)
AMC   8.31 (+9.06%)
PFE   32.70 (+0.03%)
PYPL   58.45 (+0.98%)
NFLX   384.59 (+1.26%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.17 (+0.35%)
AAPL   176.76 (+1.13%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.60 (+0.27%)
AMZN   131.38 (+1.75%)
TSLA   246.75 (+0.76%)
NVDA   424.01 (+1.90%)
NIO   8.39 (-1.64%)
BABA   87.11 (-1.35%)
AMD   96.86 (+0.69%)
T   15.07 (-0.33%)
F   12.67 (+1.93%)
MU   68.73 (-0.22%)
CGC   0.98 (+17.14%)
GE   111.72 (+0.42%)
DIS   80.83 (-0.52%)
AMC   8.31 (+9.06%)
PFE   32.70 (+0.03%)
PYPL   58.45 (+0.98%)
NFLX   384.59 (+1.26%)
S&P 500   4,332.88 (+0.30%)
DOW   33,971.77 (+0.02%)
QQQ   359.17 (+0.35%)
AAPL   176.76 (+1.13%)
MSFT   316.66 (-0.11%)
META   298.88 (-0.07%)
GOOGL   130.60 (+0.27%)
AMZN   131.38 (+1.75%)
TSLA   246.75 (+0.76%)
NVDA   424.01 (+1.90%)
NIO   8.39 (-1.64%)
BABA   87.11 (-1.35%)
AMD   96.86 (+0.69%)
T   15.07 (-0.33%)
F   12.67 (+1.93%)
MU   68.73 (-0.22%)
CGC   0.98 (+17.14%)
GE   111.72 (+0.42%)
DIS   80.83 (-0.52%)
AMC   8.31 (+9.06%)
PFE   32.70 (+0.03%)
PYPL   58.45 (+0.98%)
NFLX   384.59 (+1.26%)
NASDAQ:ALGN

Align Technology (ALGN) Stock Forecast, Price & News

$295.06
-3.50 (-1.17%)
(As of 12:16 PM ET)
Compare
Today's Range
$293.42
▼
$298.55
50-Day Range
$298.56
▼
$385.31
52-Week Range
$172.05
▼
$413.20
Volume
184,489 shs
Average Volume
827,131 shs
Market Capitalization
$22.58 billion
P/E Ratio
72.50
Dividend Yield
N/A
Price Target
$380.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Align Technology MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
28.9% Upside
$380.33 Price Target
Short Interest
Healthy
2.91% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.34
Upright™ Environmental Score
News Sentiment
1.11mentions of Align Technology in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.25%
From $7.21 to $8.67 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.97 out of 5 stars

Medical Sector

36th out of 963 stocks

Surgical Appliances & Supplies Industry

4th out of 18 stocks

See Top Rated MarketRank™ Stocks Here

ALGN stock logo

About Align Technology (NASDAQ:ALGN) Stock

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

ALGN Price History

ALGN Stock News Headlines

September 25, 2023 | americanbankingnews.com
Brokers Offer Predictions for Align Technology, Inc.'s Q4 2023 Earnings (NASDAQ:ALGN)
September 23, 2023 | americanbankingnews.com
Align Technology, Inc. (NASDAQ:ALGN) Expected to Earn Q3 2023 Earnings of $1.78 Per Share
September 25, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
September 22, 2023 | msn.com
Down -14.38% in 4 Weeks, Here's Why You Should You Buy the Dip in Align Technology (ALGN)
September 20, 2023 | seekingalpha.com
Align Technology Isn't Cheap Enough
September 19, 2023 | tmcnet.com
Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit
September 19, 2023 | businesswire.com
Align Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share ...
September 19, 2023 | americanbankingnews.com
Align Technology, Inc. (NASDAQ:ALGN) Short Interest Update
September 25, 2023 | Wall Street Fundamentals (Ad)
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
September 16, 2023 | americanbankingnews.com
Align Technology (NASDAQ:ALGN) Lifted to Positive at OTR Global
September 13, 2023 | finance.yahoo.com
Here's Why Align Technology (ALGN) is Poised for a Turnaround After Losing -10.74% in 4 Weeks
September 11, 2023 | msn.com
Align Technologies (ALGN) Brings New Upgrades for Oral Health
September 9, 2023 | msn.com
Align Technologies (ALGN) Set to Acquire Cubicure GmbH
September 7, 2023 | businesswire.com
Align Technology Introduces the Invisalign ® Palatal Expander System to Address Skeletal Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority ...
September 7, 2023 | markets.businessinsider.com
Align Tech (ALGN) Receives a Hold from Goldman Sachs
September 6, 2023 | tmcnet.com
Align Technology Introduces Invisalign® System Innovation for Greater Control of Digital Treatment Planning With Integration of Plan
September 6, 2023 | markets.businessinsider.com
Align Technology To Buy Privately-held Cubicure For EUR 79 Mln
September 6, 2023 | finance.yahoo.com
Align Technology Introduces New SmartForce™ Attachment-free Aligner Activation Feature
September 6, 2023 | finance.yahoo.com
Align Technology Introduces New Software Innovations Designed to Accelerate Digital Practice Transformation
September 6, 2023 | finance.yahoo.com
Align Technology Introduces Invisalign® System Innovation for Greater Control of Digital Treatment Planning With Integration of Plan Editor Into ClinCheck® Treatment Planning Software
September 6, 2023 | finance.yahoo.com
Align Technology to Acquire Privately Held Direct 3D Printing Pioneer Cubicure to Support and Scale Company’s Strategic Innovation Roadmap
September 6, 2023 | finance.yahoo.com
Align Technology Introduces New Vivera Retainer Doctor Enabled Direct Ship to Patient Feature in Its Doctor Subscription Program
September 6, 2023 | finance.yahoo.com
Align Technology Launches Customer Education and Training Center in Toronto, Canada
September 6, 2023 | finance.yahoo.com
Align Technology Introduces the Invisalign® Palatal Expander System to Address Skeletal Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally
August 31, 2023 | finance.yahoo.com
Cooper Companies (COO) Q3 Earnings In Line, '23 Outlook Raised
August 30, 2023 | markets.businessinsider.com
4 Analysts Have This to Say About Align Tech
August 29, 2023 | msn.com
Align Technology: Commanding Position But Balanced Risk-Reward
See More Headlines
Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Company Calendar

Last Earnings
7/26/2023
Today
9/25/2023
Next Earnings (Estimated)
10/25/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ALGN
CUSIP
01625510
CIK
1097149
Web
www.aligntech.com
Phone
(602) 742-2000
Fax
408-470-1010
Employees
23,165
Year Founded
1997

Price Target and Rating

Average Stock Price Forecast
$380.33
High Stock Price Forecast
$450.00
Low Stock Price Forecast
$225.00
Forecasted Upside/Downside
+27.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$4.07
Trailing P/E Ratio
73.36
Forward P/E Ratio
41.41
P/E Growth
2.36
Net Income
$361.57 million
Net Margins
8.40%
Pretax Margin
14.56%
Return on Equity
11.42%
Return on Assets
6.89%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.17
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$3.73 billion
Price / Sales
6.12
Cash Flow
$7.69 per share
Price / Cash Flow
38.83
Book Value
$46.10 per share
Price / Book
6.48

Miscellaneous

Outstanding Shares
76,530,000
Free Float
76,044,000
Market Cap
$22.85 billion
Optionable
Optionable
Beta
1.63

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Joseph M. HoganMr. Joseph M. Hogan (Age 66)
    Pres, CEO & Director
  • Mr. John F. MoriciMr. John F. Morici (Age 56)
    CFO & Exec. VP of Global Fin.
  • Mr. Emory M. WrightMr. Emory M. Wright (Age 53)
    Exec. VP of Global Operations
    Comp: $538.01k
  • Ms. Julie Ann ColettiMs. Julie Ann Coletti (Age 54)
    Exec. VP and Chief Legal & Regulatory Officer
    Comp: $527.99k
  • Mr. Stuart HockridgeMr. Stuart Hockridge (Age 51)
    Exec. VP of Global HR
    Comp: $495.63k
  • Mr. Zelko RelicMr. Zelko Relic (Age 58)
    Exec. VP & CTO
  • Ms. Shirley Stacy
    VP of Corp. Communications & Investor Relations
  • Mr. Vamsi Mohan-Raj Pudipeddi (Age 51)
    Exec. VP, Chief Product & Marketing Officer and MD of Asia Pacific
  • Mr. Simon BeardMr. Simon Beard (Age 56)
    MD for Americas and EMEA Region & Exec. VP
  • Ms. Jennifer Olson-Wilk (Age 45)
    Exec. VP of Customer Success

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ALGN Stock - Frequently Asked Questions

Should I buy or sell Align Technology stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALGN shares.
View ALGN analyst ratings or view top-rated stocks.

What is Align Technology's stock price forecast for 2023?

9 brokers have issued 1 year price targets for Align Technology's shares. Their ALGN share price forecasts range from $225.00 to $450.00. On average, they expect the company's share price to reach $380.33 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price.
View analysts price targets for ALGN or view top-rated stocks among Wall Street analysts.

How have ALGN shares performed in 2023?

Align Technology's stock was trading at $210.90 on January 1st, 2023. Since then, ALGN stock has increased by 41.6% and is now trading at $298.56.
View the best growth stocks for 2023 here.

Are investors shorting Align Technology?

Align Technology saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 2,080,000 shares, a drop of 8.4% from the August 15th total of 2,270,000 shares. Based on an average trading volume of 708,600 shares, the short-interest ratio is presently 2.9 days. Currently, 2.9% of the company's shares are sold short.
View Align Technology's Short Interest.

When is Align Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 25th 2023.
View our ALGN earnings forecast.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) issued its quarterly earnings data on Wednesday, July, 26th. The medical equipment provider reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.09. The medical equipment provider earned $1 billion during the quarter, compared to the consensus estimate of $985.87 million. Align Technology had a trailing twelve-month return on equity of 11.42% and a net margin of 8.40%.

What ETFs hold Align Technology's stock?

ETFs with the largest weight of Align Technology (NASDAQ:ALGN) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Guru Favorite Stocks ETF (GFGF), Upholdings Compound Kings ETF (KNGS), BNY Mellon Innovators ETF (BKIV), BlackRock Future Health ETF (BMED), AI Quality Growth ETF (AQGX), First Trust Indxx Medical Devices ETF (MDEV) and Hartford Large Cap Growth ETF (HFGO).

What guidance has Align Technology issued on next quarter's earnings?

Align Technology issued an update on its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.97 billion-$3.99 billion, compared to the consensus revenue estimate of $3.94 billion.

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.31%), Bank Julius Baer & Co. Ltd Zurich (5.88%), State Street Corp (3.99%), Capital World Investors (2.76%), Sands Capital Management LLC (2.69%) and Geode Capital Management LLC (2.08%). Insiders that own company stock include Andrea Lynn Saia, C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph M Hogan, Julie Ann Coletti, Kevin C Burns, Kevin J Dallas, Robert E Fitzgerald, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends.

How do I buy shares of Align Technology?

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $298.56.

How much money does Align Technology make?

Align Technology (NASDAQ:ALGN) has a market capitalization of $22.85 billion and generates $3.73 billion in revenue each year. The medical equipment provider earns $361.57 million in net income (profit) each year or $4.07 on an earnings per share basis.

How many employees does Align Technology have?

The company employs 23,165 workers across the globe.

Does Align Technology have any subsidiaries?
The following companies are subsidiares of Align Technology: Align Technology Switzerland GmbH, Cadent, G.L. Dental Couture, and exocad Global Holdings GmbH (“exocad”).
Read More
How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.aligntech.com. The medical equipment provider can be reached via phone at (602) 742-2000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.

This page (NASDAQ:ALGN) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -